Christine M Posavad

Title: Christine M Posavad: Innovator in Herpes Simplex Virus Research

Introduction

Christine M Posavad is a notable inventor based in Seattle, WA (US). She has made significant contributions to the field of immunology, particularly in the development of herpes simplex virus (HSV) antigens. With a total of 4 patents, her work focuses on innovative methods for the prevention and treatment of HSV infections.

Latest Patents

Christine's latest patents include groundbreaking inventions related to immunologically significant herpes simplex virus antigens. These inventions provide HSV antigens that are useful for both the prevention and treatment of HSV infection. The patents disclose epitopes that have been confirmed to be recognized by T-cells derived from herpetic lesions. T-cells that are specific to these antigens have demonstrated cytotoxic activity against cells loaded with virally-encoded peptide epitopes, and in many cases, against cells infected with HSV. The identification of immunogenic antigens responsible for T-cell specificity offers improved anti-viral therapeutic and prophylactic strategies. Compositions containing these antigens or polynucleotides encoding them provide effectively targeted vaccines for the prevention and treatment of HSV infection.

Career Highlights

Christine has worked with prestigious institutions such as the University of Washington and Fred Hutchinson Cancer Center. Her research has significantly advanced the understanding of HSV and its treatment options.

Collaborations

Some of her notable coworkers include David Martin Koelle and Nancy Ann Hosken. Their collaborative efforts have contributed to the success of her research and innovations.

Conclusion

Christine M Posavad is a pioneering inventor whose work in HSV research has the potential to transform therapeutic approaches to viral infections. Her contributions continue to impact the field of immunology and provide hope for effective treatments.